Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2019-05-10 2019-05-10
Drug Identification Number Not Applicable/non applicable Not Applicable/non applicable
Brand name THALLIUM THALLIUM
Common or Proper name Tl-201 Injection Tl-201 Injection
Company Name LANTHEUS MI CANADA INC LANTHEUS MI CANADA INC
Ingredients THALLIUM CHLORIDE THALLIUM CHLORIDE
Strength(s) 2MCI 2MCI
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10mL glass vial 10mL glass vial
ATC code V09GX V09GX
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-15 2019-03-15
Estimated end date
Actual end date 2019-05-10 2019-05-10
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments